Epidemiology of Drug Abuse

Applicants Eligible for this Grant

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments Special district governments Public housing authorities/Indian housing authorities City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized) Private institutions of higher education County governments Small businesses For profit organizations other than small businesses

Additional Information on Eligibility

Information not provided

Grant Description

This program announcement (PA) replaces PA-99-002, Epidemiologic Research on Drug Abuse, published in the NIH Guide, October 2, 1998; PA-99-113, Drug Use and Related Adverse Behavioral and Social Consequences, published in the NIH Guide, June 18, 1999; and PAR 99-168, Research on the Origins and Pathways to Drug Abuse. This new PA encourages a broad range of epidemiologic research on drug use, abuse, and dependence. It highlights new areas for research that emphasize the vital public health role of epidemiologic research in drug abuse.The major goal of this PA is to stimulate innovative investigations that enhance our understanding of: (1) drug use patterns and trends within and across populations; (2) interplay of social interactions, social environment, structural context with individual behavioral characteristics and genetic vulnerability; (3) the phenotypic heterogeneity of drug abuse; (4) causal mechanisms leading to onset, maintenance, and remittance of drug abuse, as well as protective mechanisms that reduce the risk of drug abuse; and (5) drug abuse over the life course, including developmental processes that influence drug use trajectories and behavioral, health, and social consequences of drug abuse. In addition, research is encouraged to develop methodologies to improve the accuracy, efficiency, scope, timeliness, and analytic yield of drug abuse epidemiologic data. Because of the breadth of epidemiology research, applications are anticipated to reflect diverse and multidisciplinary putative approaches and multiple levels of causation. To take advantage of the strength of specific research fields in an efficient manner, and to maximize the generalizability of findings, researchers are encouraged to develop and/or incorporate innovations in epidemiologic study design. Such designs may include nesting of biological and/or basic research, contextual analysis, and contemporary longitudinal analyses.

Link to Full Grant Announcement

http://grants.nih.gov/grants/guide/pa-files/PA-04-100.html http://grants.nih.gov/grants/guide/pa-files/PA-04-100.html

Grant Announcement Contact

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster

Similar Government Grants

• NIDA Research Center of Excellence Grant Program (P50)

• Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R21)

• Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R01)

• Medications Development Centers of Excellence Cooperative Program (U54)

• Drug Abuse Dissertation Research (R36)

• NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards

• Drug Abuse Aspects of Hiv/Aids and Other Infections

• Prescription Drug Abuse

More Grants from the National Institutes of Health

• Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...

• Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...

• Pediatric Critical Care and Trauma Scientist Development Program (K12)

• Evidence-based Demonstration Projects in Immunization (Admin Supp)

• Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...